β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction.

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/31674

Title:	β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction.
Authors:	Dondo, Tatendashe B Hall, Marlous West, Robert M Jernberg, Tomas Lindahl, Bertil Bueno, Hector Danchin, Nicolas Deanfield, John E Hemingway, Harry Fox, Keith A A Timmis, Adam D Gale, Chris P View more
Keywords:	NSTEMI STEMI average treatment effect preserved left ventricular systolic function propensity score survival View more
Mesh:	Adrenergic beta-Antagonists Aged Dose-Response Relationship, Drug Electrocardiography Female Follow-Up Studies Heart Failure Hospital Mortality Humans Male Middle Aged Myocardial Infarction Propensity Score Prospective Studies Survival Rate United Kingdom Ventricular Dysfunction Registries View more
Issue Date:	6-Jun-2017
Citation:	J. Am. Coll. Cardiol..2017 Jun;(69)22:2710-2720
Abstract:	For acute myocardial infarction (AMI) without heart failure (HF), it is unclear if β-blockers are associated with reduced mortality.
PMID:	28571635
URI:	https://hdl.handle.net/20.500.12530/31674
Rights:	openAccess
Appears in Collections:	Fundaciones e Institutos de Investigación > IIS H. U. 12 de Octubre > Artículos

Files in This Item:

File	Description	Size	Format
PMC5457288.pdf		1.33 MB	Adobe PDF	View/Open